A detailed history of Motco transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Motco holds 45 shares of GILD stock, worth $3,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$3,963
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$71.58 - $87.29 $214 - $261
-3 Reduced 6.25%
45 $3,000
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $1,404 - $1,532
-19 Reduced 28.36%
48 $3,000
Q2 2023

Aug 04, 2023

SELL
$76.01 - $86.7 $19,686 - $22,455
-259 Reduced 79.45%
67 $5,000
Q1 2023

May 09, 2023

SELL
$77.31 - $88.08 $10,823 - $12,331
-140 Reduced 30.04%
326 $27,000
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $26,236 - $37,666
421 Added 935.56%
466 $40,000
Q3 2022

Nov 03, 2022

SELL
$59.54 - $68.01 $10,479 - $11,969
-176 Reduced 79.64%
45 $3,000
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $12,800 - $16,040
221 New
221 $13,000
Q1 2021

Apr 16, 2021

SELL
$60.0 - $68.46 $2,700 - $3,080
-45 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $12,463 - $14,201
-220 Reduced 83.02%
45 $3,000
Q1 2020

May 06, 2020

BUY
$62.63 - $80.22 $1,189 - $1,524
19 Added 7.72%
265 $20,000
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $1,602 - $1,762
26 Added 11.82%
246 $16,000
Q3 2019

Nov 05, 2019

SELL
$62.51 - $69.0 $29,379 - $32,430
-470 Reduced 68.12%
220 $14,000
Q2 2019

Aug 07, 2019

BUY
$61.87 - $69.38 $29,078 - $32,608
470 Added 213.64%
690 $47,000
Q1 2019

May 02, 2019

SELL
$62.53 - $70.05 $13,381 - $14,990
-214 Reduced 49.31%
220 $14,000
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $1,755 - $2,291
-29 Reduced 6.26%
434 $27,000
Q1 2018

May 08, 2018

SELL
$72.84 - $88.8 $2,258 - $2,752
-31 Reduced 6.28%
463 $35,000
Q2 2017

Aug 08, 2017

BUY
N/A
494
494 $35,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Motco Portfolio

Follow Motco and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.